000			01927 a2200577 4500
005			20250514234007.0
264		0	_c20060314
008			200603s 0 0 eng d
022			_a0340-7004
024	7		_a10.1007/s00262-005-0018-5 _2doi
040			_aNLM _beng _cNLM
100	1		_aHaanen, J B A G
245	0	0	_aMelanoma-specific tumor-infiltrating lymphocytes but not circulating melanoma-specific T cells may predict survival in resected advanced-stage melanoma patients. _h[electronic resource]
260			_bCancer immunology, immunotherapy : CII _cApr 2006
300			_a451-8 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article
650	0	4	_aAdjuvants, Immunologic _xadministration & dosage
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntibody Formation
650	0	4	_aAntigens, Neoplasm
650	0	4	_aBCG Vaccine _xadministration & dosage
650	0	4	_aCD8-Positive T-Lymphocytes
650	0	4	_aCancer Vaccines _ximmunology
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aLymphocytes, Tumor-Infiltrating _ximmunology
650	0	4	_aMale
650	0	4	_aMelanoma _ximmunology
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasm Staging
650	0	4	_aPredictive Value of Tests
650	0	4	_aPrognosis
650	0	4	_aSkin Neoplasms _ximmunology
650	0	4	_aSurvival
650	0	4	_aTreatment Outcome
650	0	4	_aTumor Cells, Cultured _ximmunology
700	1		_aBaars, A
700	1		_aGomez, R
700	1		_aWeder, P
700	1		_aSmits, M
700	1		_ade Gruijl, T D
700	1		_avon Blomberg, B M E
700	1		_aBloemena, E
700	1		_aScheper, R J
700	1		_avan Ham, S M
700	1		_aPinedo, H M
700	1		_avan den Eertwegh, A J M
773	0		_tCancer immunology, immunotherapy : CII _gvol. 55 _gno. 4 _gp. 451-8
856	4	0	_uhttps://doi.org/10.1007/s00262-005-0018-5 _zAvailable from publisher's website
999			_c15688946 _d15688946